Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Diagnosis of atypical myopathy based on organic acid and acylcarnitine profiles and evolution of biomarkers in surviving horses.
Abstract: Atypical myopathy (AM), an acquired multiple acyl-CoA dehydrogenase deficiency (MADD) in horses, induce changes in mitochondrial metabolism. Only few veterinary laboratories offer diagnostic testing for this disease. Inborn and acquired MADD exist in humans, therefore determination of organic acids (OA) in urine and acylcarnitines (AC) in blood by assays available in medical laboratories can serve as AM diagnostics. The evolution of OA and AC profiles in surviving horses is unreported. Methods: AC profiles using electrospray ionization tandem mass spectrometry (ESI-MS/MS) and OA in urine using gas chromatography mass spectrometry (GC-MS) were determined in dried blot spots (DBS, n = 7) and urine samples (n = 5) of horses with AM (n = 7) at disease presentation and in longitudinal samples from 3/4 survivors and compared to DBS (n = 16) and urine samples (n = 7) from control horses using the Wilcoxon test. Results: All short- (C2-C5) and medium-chain (C6-C12) AC in blood differed significantly (p < 0.008) between horses with AM and controls, except for C5:1 (p = 0.45) and C5OH + C4DC (p = 0.06). In AM survivors the AC concentrations decreased over time but were still partially elevated after 7 days. 14/62 (23%) of OA differed significantly between horses with AM and control horses. Concentrations of ethylmalonic acid, 2-hydroxyglutaric acid and the acylglycines (butyryl-, valeryl-, and hexanoylglycine) were highly elevated in the urine of all horses with AM at the day of disease presentation. In AM survivors, concentrations of those metabolites were initially lower and decreased during remission to approach normalization after 7 days. Conclusions: OA and AC profiling by specialized human medical laboratories was used to diagnose AM in horses. Elevation of specific metabolites were still evident several days after disease presentation, allowing diagnosis via analysis of samples from convalescent animals.
© 2021 Published by Elsevier Inc.
Publication Date: 2021-11-25 PubMed ID: 34900597PubMed Central: PMC8639802DOI: 10.1016/j.ymgmr.2021.100827Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The paper explores diagnosing Atypical myopathy (AM), a mitochondrial metabolic disorder seen in horses, by assessing organic acids in urine and acylcarnitines in blood. It also investigates how these markers change over time in horses that survive the disease.
Context and Objectives
- Atypical myopathy (AM) is a condition seen in horses that results in changes in mitochondrial metabolism. It is similar to both inborn and acquired multiple acyl-CoA dehydrogenase deficiency (MADD) in humans.
- Few veterinary laboratories offer specific testing for this disease. As such, medical laboratory tests developed for human MADD for organic acids (OA) in urine and acylcarnitines (AC) in blood could serve as diagnostic tools.
- This study seeks to explore the efficacy of using these diagnostic tests for horses suffering from AM and to understand how the profile of these biomarkers evolves in horses which survive the disease.
Methods
- Blood and urine samples were taken from horses with AM and compared to samples from healthy control horses.
- Organic acid profiles in urine were tested by gas chromatography mass spectrometry (GC-MS) and acylcarnitines profiles in blood were determined using electrospray ionization tandem mass spectrometry (ESI-MS/MS).
- These samples were taken at the time of disease presentation and then regularly afterward from surviving horses to study the changes over time.
Results
- All short-chain and medium-chain acylcarnitines in blood were significantly different in horses suffering from AM compared to healthy horses, except for two specific types.
- In comparison, 23% of organic acids showed significant differences between affected and healthy horses.
- At the time of disease presentation, several specific metabolites (ethylmalonic acid, 2-hydroxyglutaric acid, butyryl-, valeryl-, and hexanoylglycine) were found to be elevated in the urine of horses with AM.
- For AM survivors, these elevated concentrations decreased during the period of recovery, approaching regular levels after roughly seven days.
Conclusion
- The organic acid and acylcarnitine profiling tests traditionally used by human medical laboratories could be used to diagnose atypical myopathy in horses.
- Certain metabolite elevations were evident for several days after disease onset, allowing for disease diagnosis from samples collected from recovering animals.
Cite This Article
APA
Mathis D, Sass JO, Graubner C, Schoster A.
(2021).
Diagnosis of atypical myopathy based on organic acid and acylcarnitine profiles and evolution of biomarkers in surviving horses.
Mol Genet Metab Rep, 29, 100827.
https://doi.org/10.1016/j.ymgmr.2021.100827 Publication
Researcher Affiliations
- University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich, Zurich, Switzerland.
- Department of Natural Sciences & Institute for Functional Gene Analytics (IFGA), Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany.
- Institut Suisse de Médecine Equine, Vetsuisse Faculty, University of Berne, Länggassstrasse 124, 3012 Berne, Switzerland.
- Clinic for Equine Internal Medicine, Equine Department, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
Conflict of Interest Statement
The authors have no competing interest to declare.
References
This article includes 22 references
- Votion D.M., van Galen G., Sweetman L., Boemer F., de Tullio P., Dopagne C., Lefere L., Mouithys-Mickalad A., Patarin F., Rouxhet S., van Loon G., Serteyn D., Sponseller B.T., Valberg S.J.. Identification of methylenecyclopropyl acetic acid in serum of European horses with atypical myopathy.. Equine Vet. J. 2014;46:146–149.
- Valberg S.J., Sponseller B.T., Hegeman A.D., Earing J., Bender J.B., Martinson K.L., Patterson S.E., Sweetman L.. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree.. Equine Vet. J. 2013;45:419–426.
- van der Kolk J.H., Wijnberg I.D., Westermann C.M., Dorland L., de Sain-van M.G., der Velden L.C., Kranenburg M., Duran J.A., van der Dijkstra J.J., Lugt R.J., Wanders E.Gruys. Equine acquired multiple acyl-CoA dehydrogenase deficiency (MADD) in 14 horses associated with ingestion of maple leaves (Acer pseudoplatanus) covered with european tar spot (Rhytisma acerinum). Mol. Genet. Metab. 2010;101:289–291.
- Unger-Torroledo L., Straub R., Lehmann A.D., Graber F., Stahl C., Frey J., Gerber V., Hoppeler H., Baum O.. Lethal toxin of Clostridium sordellii is associated with fatal equine atypical myopathy.. Vet. Microbiol. 2010;144:487–492.
- Westermann C.M., Dorland L., Votion D.M., de Sain-van der Velden M.G., Wijnberg I.D., Wanders R.J., Spliet W.G., Testerink N., Berger R., Ruiter J.P., van der Kolk J.H.. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.. Neuromuscul. Disord. 2008;18:355–364.
- Meda H.A., Diallo B., Buchet J.P., Lison D., Barennes H., Ouangre A., Sanou M., Cousens S., Tall F., P. Van de perre. Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit.. Lancet 1999;353:536–540.
- Joskow R., Belson M., Vesper H., Backer L., Rubin C.. Ackee fruit poisoning: an outbreak investigation in Haiti 2000–2001, and review of the literature.. Clin. Toxicol. (Phila.) 2006;44:267–273.
- Isenberg S.L., Carter M.D., Graham L.A., Mathews T.P., Johnson D., Thomas J.D., Pirkle J.L., Johnson R.C.. Quantification of metabolites for assessing human exposure to soapberry toxins hypoglycin A and methylenecyclopropylglycine.. Chem. Res. Toxicol. 2015;28:1753–1759.
- Fowden L., Pratt H.M.. Cyclopropylamino acids of the genus Acer: distribution and biosynthesis.. Phytochemistry 1972;12:5.
- Unger L., Nicholson A., Jewitt E.M., Gerber V., Hegeman A., Sweetman L., Valberg S.. Hypoglycin a concentrations in seeds of Acer pseudoplatanus trees growing on atypical myopathy-affected and control pastures.. J.Vet.Int.Med. 2014;28:1289–1293.
- Mereis M., Wanders R.J.A., Schoonen M., Dercksen M., Smuts I., van der Westhuizen F.H.. Disorders of flavin adenine dinucleotide metabolism: MADD and related deficiencies.. Int. J. Biochem. Cell Biol. 2021;132.
- Henriques B.J., Olsen R.Katrine Jentoft, Gomes C.M., Bross P.. Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease.. Gene 2021;776.
- Karlikova R., Siroka J., Jahn P., Friedecky D., Gardlo A., Janeckova H., Hrdinova F., Drabkova Z., Adam T.. Equine atypical myopathy: a metabolic study.. Vet. J. 2016;216:125–132.
- Bochnia M., Scheidemann W., Ziegler J., Sander J., Vollstedt S., Glatter M., Janzen N., Terhardt M., Zeyner A.. Predictive value of hypoglycin A and methylencyclopropylacetic acid conjugates in a horse with atypical myopathy in comparison to its cograzing partners.. Equine Vet .Educ. 2018;30:24–28.
- Bochnia M., Ziegler J., Sander J., Uhlig A., Schaefer S., Vollstedt S., Glatter M., Abel S., Recknagel S., Schusser G.F., Wensch-Dorendorf M., Zeyner A.. Hypoglycin A content in blood and urine discriminates horses with atypical myopathy from clinically normal horses grazing on the same pasture.. PLoS One 2015;10.
- Boemer F., Detilleux J., Cello C., Amory H., Marcillaud-Pitel C., Richard E., van Galen G., van Loon G., Lefere L., Votion D.M.. Acylcarnitines profile best predicts survival in horses with atypical myopathy.. PLoS One 2017;12.
- Rashed M.S., Ozand P.T., Bucknall M.P., Little D.. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.. Pediatr. Res. 1995;38:324–331.
- Tanaka K., West-Dull A., Hine D.G., Lynn T.B., Lowe T.. Gas-chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias.. Clin. Chem. 1980;26:1847–1853.
- Sponseller B.T., Valberg S.J., Schultz N.E., Bedford H., Wong D.M., Kersh K., Shelton G.D.. Equine multiple acyl-CoA dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the midwestern United States.. J. Vet. Intern. Med. 2012;26:1012–1018.
- Votion D.M., Linden A., Saegerman C., Engels P., Erpicum M., Thiry E., Delguste C., Rouxhet S., Demoulin V., Navet R., Sluse F., Serteyn D., van Galen G., Amory H.. History and clinical features of atypical myopathy in horses in Belgium (2000-2005). J. Vet. Intern. Med. 2007;21:1380–1391.
- Onkenhout W., Venizelos V., van der Poel P.F., van den Heuvel M.P., Poorthuis B.J.. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders.. Clin. Chem. 1995;41:1467–1474.
- Costa C.G., Dorland L., Holwerda U., de Almeida I.T., Poll-The B.T., Jakobs C., Duran M.. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.. Clin. Chem. 1998;44:463–471.
Citations
This article has been cited 4 times.- François AC, Taminiau B, Renaud B, Gonza-Quito IE, Massey C, Hyde C, Piercy RJ, Douny C, Scippo ML, Daube G, Gustin P, Delcenserie V, Votion DM. In Vitro Investigation of Equine Gut Microbiota Alterations During Hypoglycin A Exposure. Animals (Basel) 2025 Nov 19;15(22).
- François AC, Cesarini C, Taminiau B, Renaud B, Kruse CJ, Boemer F, van Loon G, Palmers K, Daube G, Wouters CP, Lecoq L, Gustin P, Votion DM. Unravelling Faecal Microbiota Variations in Equine Atypical Myopathy: Correlation with Blood Markers and Contribution of Microbiome. Animals (Basel) 2025 Jan 26;15(3).
- Kruse CJ, Dieu M, Renaud B, François AC, Stern D, Demazy C, Burteau S, Boemer F, Art T, Renard P, Votion DM. New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy. ACS Omega 2024 Feb 13;9(6):6505-6526.
- Jahn P, Dobešová D, Brumarová R, Tóthová K, Kopecká A, Friedecký D. Dynamics of acylcarnitines, hypoglycin A, méthylènecyclopropylglycine and their metabolites in a Kladruber stallion with atypical myopathy. Vet Q 2022 Dec;42(1):183-191.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
